Mariottini, Alice
De Matteis, Eleonora
Cencioni, Maria Teresa
Muraro, Paolo A. http://orcid.org/0000-0002-3822-1218
Funding for this research was provided by:
Efficacy and Mechanism Evaluation Programme (16/126/26)
NIHR Imperial Biomedical Research Centre
Article History
Accepted: 18 July 2023
First Online: 17 August 2023
Declarations
:
: Dr. Mariottini reports personal fees from Sanofi, personal fees from Novartis, personal fees from Biogen, non-financial support from Sanofi, non-financial support from Biogen, non-financial support from Janssen Neuroscience and non-financial support from Merck, outside the submitted work. Dr. De Matteis has nothing to disclose. Dr. Cencioni has nothing to disclose. Prof. Muraro reports grants from National Institute of Health Research, non-financial support from National Institute of Health Research and grants from Benaroya Research Institute and National Institute of Allergy and Infectious Diseases of the National Institutes of Health, during the conduct of the study, and personal fees from Jasper Therapeutics, personal fees from Magenta Therapeutics, personal fees from Quell Therapeutics and personal fees from Rubius Therapeutics, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.